We’re Here for You! Coronavirus (COVID-19) Updates
Schedule Your COVID Vaccine – check availability

Central Maine Healthcare

Changing the Face of Healthcare in Maine

Home About Us ACO Public Reporting

ACO Public Reporting

 

Central Maine ACO Public Reporting

ACO Name and Location

Central Maine ACO
300 Main Street
Lewiston, Maine 04240

ACO Primary Contact

Jeff Buck
207-795-2953
buckje2@cmhc.org

 

ACO participants

ACO Participants ACO Participant in Joint Venture
Central Maine Clinical Associates Corporation N
DFD Russell Medical Center Inc N
Stephen R Barter MD N
Freeport Medical Center, PA N
Androscoggin Home Health Services, Inc. N
Tri-County Mental Health Services N
Rumford Hospital N
Wilson Stream Family Practice LLC, PA N
Parkview Medical Associates, PA N
Central Maine Medical Center N
Knapp Family Practice, Llc N
Rumford Community Family Health Center Inc. N
Bridgton Hospital N
Lewiston Operations Llc (D/B/A Marshwood Center) N

 

ACO governing body:

 

 

 

Member
Last Name		 Member
First Name		 Member Title/
Position		 Member’s Voting Power:
expressed as a
percentage
or number		 Membership
Type		 ACO Participant
Legal Business
Name/DBA, if applicable
Alexander John President 0% ACO Participant
representative		 Central Maine Medical Center
Littleson Steve 12% ACO Participant
representative		 Central Maine Medical Center
Wright Peter 12% ACO Participant
representative		 Bridgton Hospital
Salko David 12% ACO Participant
representative		 Central Maine Medical Center
Packer Joel 12% Medicare beneficiary
representative
Kane-Lewis Laurie 12% ACO Participant
representative		 DFD Russell Medical Center Inc.
Cave Cynthia 12% ACO Participant
representative		 Lewiston Operations, Llc
(D/B/A Marshwood Center)
Albert Ken 12% ACO Participant
representative		 Androscoggin  Home Health Services, Inc.
Knapp Michelle 12% ACO Participant
representative		 Knapp Family Practice, Llc

 

Key ACO clinical and administrative leadership:

ACO Executive: Jeff Buck
Medical Director: John Alexander, M.D.
Compliance Officer: Betsey Shew, Esq. CPHQ, CMC
Quality Assurance/Improvement Officer: Rebekah Dube, Pharm.D.

Associated committees and committee leadership:

Committee Name Committee Leader Name and Position
Provider Advisory Group John Alexander, MD; Chair
Ambulatory Quality Committee Michael Stadnicki, MD; Chair

Types of ACO participants, or combinations of participants, that formed the ACO:

  • ACO professionals in a group practice arrangement
  • Networks of individual practices of ACO professionals
  • Partnerships or joint venture arrangements between hospitals and ACO professionals
  • Hospital employing ACO professionals
  • Critical Access Hospital (CAH) billing under Method II
  • Federally Qualified Health Center (FQHC)
  • Rural Health Clinic (RHC)

Shared Savings and Losses

Amount of Shared Savings/Losses:

  • Third Agreement Period
    • Performance Year 2020, $0
    • Performance Year 2019, $0
      Note: Our ACO participated in multiple performance years during Calendar Year 2019. Shared savings/losses amount reported for Performance Year 2019 therefore represents net shared savings or losses across all performance years in 2019 and is shown under all agreement periods in which the ACO operated during Calendar Year 2019.
  • Second Agreement Period
    • Performance Year 2018, $0
    • Performance Year 2017, $0
    • Performance Year 2016, $0
  • First Agreement Period
      • Performance Year 2015, $0
      • Performance Year 2014, $0
      • Performance Year 2013, $0

Shared Savings Distribution:

  • Third Agreement Period
  • Performance Year 2020
    • Proportion invested in infrastructure: N/A%
    • Proportion invested in redesigned care processes/resources: N/A%
    • Proportion of distribution to ACO participants: N/A%
  • Performance Year 2019
    • Proportion invested in infrastructure: N/A%
    • Proportion invested in redesigned care processes/resources: N/A%
    • Proportion of distribution to ACO participants: N/A%
  • Second Agreement Period
    • Performance Year 2018
      • Proportion invested in infrastructure: N/A
      • Proportion invested in redesigned care processes/resources: N/A
      • Proportion of distribution to ACO participants: N/A
    • Performance Year 2017
      • Proportion invested in infrastructure: N/A
      • Proportion invested in redesigned care processes/resources: N/A
      • Proportion of distribution to ACO participants: N/A
    • Performance Year 2016
        • Proportion invested in infrastructure: N/A
        • Proportion invested in redesigned care processes/resources: N/A
        • Proportion of distribution to ACO participants: N/A
    • First Agreement Period
      • Performance Year 2015
        • Proportion invested in infrastructure: N/A
        • Proportion invested in redesigned care processes/resources: N/A
        • Proportion of distribution to ACO participants: N/A
      • Performance Year 2014
        • Proportion invested in infrastructure: N/A
        • Proportion invested in redesigned care processes/resources: N/A
        • Proportion of distribution to ACO participants: N/A
      • Performance Year 2013
          • Proportion invested in infrastructure: N/A
          • Proportion invested in redesigned care processes/resources: N/A
          • Proportion of distribution to ACO participants: N/A

Quality Performance Results

2020 Quality Performance Results:

ACO # Measure Name Rate ACO Mean
ACO-43 Ambulatory Sensitive Condition Acute Composite (AHRQ* Prevention Quality Indicator (PQI #91)) .87 .95
ACO-13 Falls: Screening for Future Fall Risk 73.91 84.97
ACO-14 Preventive Care and Screening: Influenza Immunization 64.73 76.03
ACO-17 Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention 96.77 81.67
ACO-18 Preventive Care and Screening: Screening for Depression and Follow-up Plan 84.06 71.46
ACO-19 Colorectal Cancer Screening 63.41 72.59
ACO-20 Breast Cancer Screening 67.11 74.05
ACO-42 Statin Therapy for the Prevention and Treatment of Cardiovascular Disease 88.62 83.37
ACO-27 Diabetes: Hemoglobin A1c Poor Control (>9%) 18.55 14.70
ACO-28 Controlling High Blood Pressure 79.13 72.87

Please note: the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low sample size. The Centers for Medicare & Medicaid Services (CMS) also waived the requirement for ACOs to field a CAHPS for ACOs survey for PY 2020 through the Physician Fee Schedule Final Rule for Calendar Year 2021. Additionally, CMS reverted ACO-8 Risk-Standardized, All Condition Readmission and ACO-38 Risk-Standardized Acute Admission Rates for Patients with Multiple Chronic Conditions to pay-for-reporting, given the impact of the coronavirus disease 2019 (COVID-19) public health emergency (PHE) on these measures

For Previous Years’ Financial and Quality Performance Results, Please Visit data.cms.gov

Payment Rule Waivers

  • Skilled Nursing Facility (SNF) 3-Day Rule Waiver:
    • Our ACO uses the SNF 3-Day Rule Waiver, pursuant to 42 CFR § 425.612.